Production (Stage)
Burning Rock Biotech Limited
BNR
$3.65
$0.26917.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -12.60% | -12.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -12.60% | -12.60% |
| Cost of Revenue | -- | -- | -- | -9.10% | -9.10% |
| Gross Profit | -- | -- | -- | -14.21% | -14.21% |
| SG&A Expenses | -- | -- | -- | -32.43% | -32.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -27.09% | -27.09% |
| Operating Income | -- | -- | -- | 36.19% | 36.19% |
| Income Before Tax | -- | -- | -- | 37.26% | 37.26% |
| Income Tax Expenses | -- | -- | -- | -12.55% | -12.55% |
| Earnings from Continuing Operations | -- | -- | -- | 37.19% | 37.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | 37.19% | 37.19% |
| EBIT | -- | -- | -- | 36.19% | 36.19% |
| EBITDA | -- | -- | -- | 43.10% | 43.10% |
| EPS Basic | -- | -- | -- | 36.52% | 36.52% |
| Normalized Basic EPS | -- | -- | -- | 36.59% | 36.59% |
| EPS Diluted | -- | -- | -- | 36.52% | 36.52% |
| Normalized Diluted EPS | -- | -- | -- | 36.59% | 36.59% |
| Average Basic Shares Outstanding | -- | -- | -- | -0.92% | -0.92% |
| Average Diluted Shares Outstanding | -- | -- | -- | -0.92% | -0.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |